DOCUMENT
65 -- Icospent Ethyl (IPE) and Placebo Capsules needed for Study. - Attachment
- Notice Date
- 3/31/2016
- Notice Type
- Attachment
- NAICS
- 325411
— Medicinal and Botanical Manufacturing
- Contracting Office
- Great Lakes Acquisition Center (GLAC);Department of Veterans Affairs;115 S 84th Street, Suite 101;Milwaukee WI 53214-1476
- ZIP Code
- 53214-1476
- Solicitation Number
- VA69D16N0668
- Response Due
- 4/11/2016
- Archive Date
- 6/10/2016
- Point of Contact
- Teresa Beers-Wesolowski
- E-Mail Address
-
4-4865<br
- Small Business Set-Aside
- N/A
- Description
- The William S. Middleton Memorial VA Hospital, 2500 Overlook Terrace, Madison, WI is seeking potential sources capable of providing Icosapent Ethyl (IPE) (Vascepa ®) and an olive oil placebo capsule for a (5) year Research Study. The Research Department estimates the need for 167,400 capsules of both the drug and placebo over the 5 year period. We believe the applicable NAICS code is 325412 or 325411. We are currently unaware of anyone providing a placebo for Vascepa ®. We are open to exploring different options in getting this drug or a generic alternative and a placebo to be able to complete this study. Here are some questions: "Can Vascepa ® be manufactured without the name imprinted on the capsule? Can the manufacture provide the olive oil placebo in the same blank capsule? "Can a generic version be manufactured in a blank capsule? If so, what is the formula for the generic? Can the olive oil placebo be provided as well? "If all that is available commercially is imprinted Vascepa ® Capsules, is there anyone that can remove the imprint from the capsule and also then provide the olive oil placebo to match the Vascepa ® in every way? No formal solicitation document exists at this time. Responses to this sources sought notice should include the following: name and address of company; business size (large or small); identify whether or not firm falls into any of the following socioeconomic categories - 8(a), HUBZone, Service Disabled Veteran-Owned (SDVOSB); firm's capability statement; and any other pertinent information that demonstrates the capability to meet the above requirement. All responses shall be submitted in writing no later than 5:00 PM local time, 11 April 2016, to the attention of: Teresa Beers-Wesolowski, Great Lakes Acquisition Center (GLAC), 115 South 84th St, Suite 101, Milwaukee, WI 53214. Email address: Teresa.Beers-Wesolowski@va.gov. If you have questions or require additional information, please contact Teresa via email.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/VA/VAGLHS/VAGLHCS/VA69D16N0668/listing.html)
- Document(s)
- Attachment
- File Name: VA69D-16-N-0668 VA69D-16-N-0668_1.docx (https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=2648441&FileName=VA69D-16-N-0668-002.docx)
- Link: https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=2648441&FileName=VA69D-16-N-0668-002.docx
- Note: If links are broken, refer to Point of Contact above or contact the FBO Help Desk at 877-472-3779.
- File Name: VA69D-16-N-0668 VA69D-16-N-0668_1.docx (https://www.vendorportal.ecms.va.gov/FBODocumentServer/DocumentServer.aspx?DocumentId=2648441&FileName=VA69D-16-N-0668-002.docx)
- Record
- SN04068455-W 20160402/160331234651-7d0b4642212c7da340bd39d262082c72 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |